Paradigm Asset Management CO LLC Ligand Pharmaceuticals Inc Transaction History

Paradigm Asset Management CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$74.52 - $117.06 $156,492 - $245,826	-2,100 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $38,307 - $49,755	-300 Reduced 12.5%	2,100 $324,000
Q3 2021 Nov 12, 2021	SELL	$102.33 - $144.73 $30,699 - $43,419	-300 Reduced 11.11%	2,400 $334,000
Q2 2021 Jul 30, 2021	SELL	$113.03 - $155.64 $22,606 - $31,127	-200 Reduced 6.9%	2,700 $354,000
Q1 2021 May 11, 2021	SELL	$99.52 - $215.83 $29,856 - $64,749	-300 Reduced 9.38%	2,900 $442,000
Q4 2020 Feb 12, 2021	BUY	$80.55 - $106.05 $257,760 - $339,360	3,200 New	3,200 $318,000

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.79B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Paradigm Asset Management CO LLC with notifications on news.